This compound is an active pharmaceutical ingredient impurity associated with ambrisentan. It is characterized as a diphenylpropenoic acid derivative containing a dimethylpyrimidinyloxy substituent.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Erythromycin oxime
pharmaceutical raw material
Fotagliptin
pharmaceutical raw material
ARRY-382
pharmaceutical raw material
Afatinib D6
pharmaceutical raw material
2-((2,2-Diphenylvinyl)oxy)-4,6-dimethylpyrimidine
pharmaceutical intermediate
2-(4,6-dimethylpyrimidin-2-yl)oxy-3,3-diphenylprop-2-enoic acid
RCXXMENQXDEDQY-UHFFFAOYSA-N
CC1=CC(=NC(=N1)OC(=C(C2=CC=CC=C2)C3=CC=CC=C3)C(=O)O)C
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.